Longitudinal Description of Hemorrhoidal Pathology
DeLPH
1 other identifier
observational
500
1 country
1
Brief Summary
Hemorrhoidal disease is a common cause of gastroenterology visits. In the United States, it is considered the 3rd most common gastrointestinal diagnosis with nearly 4 million scheduled or emergency visits. In France, self-reported questionnaires estimate that one person in five has suffered at least one hemorrhoidal attack in the past year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2021
CompletedFirst Posted
Study publicly available on registry
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2023
CompletedMarch 7, 2023
March 1, 2022
1 year
June 15, 2021
March 6, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
Average prolapse score before and after treatment according to the type of hemorrhoidal disease (internal, external or both).
6 months
Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
Average bleeding score before and after treatment according to the type of hemorrhoidal disease (internal, external or both).
6 months
Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
Average quality of life score before and after treatment according to the type of hemorrhoidal disease (internal, external or both).
6 months
Secondary Outcomes (4)
Evaluate the proportion of patients consulting for hemorrhoidal disease in the general proctology consultation of a specialized center that also receives emergencies
6 months
Describe the various symptoms of hemorrhoidal disease
6 months
Search for proctological pathologies associated with hemorrhoidal disease
6 months
Determine potential risk factors for hemorrhoidal disease
6 months
Eligibility Criteria
Consecutive patients consulting for hemorrhoidal disease in the proctology department of the Groupe Hospitalier Paris Saint-Joseph (GHPSJ) between January 1st 2020 and April 30th 2020
You may qualify if:
- Patient whose age is ≥ 18 years
- Consecutive patients consulting for hemorrhoidal disease at the proctology department of the Groupe Hospitalier Paris Saint-Joseph (GHPSJ) between January 1, 2020 and April 30, 2020
- French-speaking patient
You may not qualify if:
- Patient objecting to participation in the study
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2021
First Posted
June 30, 2021
Study Start
June 15, 2020
Primary Completion
June 15, 2021
Study Completion
March 6, 2023
Last Updated
March 7, 2023
Record last verified: 2022-03